# A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin

> **NCT06603285** · — · NOT_YET_RECRUITING · sponsor: **Excelsior** · enrollment: 20 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Treprostinil

## Key facts

- **NCT ID:** NCT06603285
- **Lead sponsor:** Excelsior
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-16
- **Primary completion:** 2029-05-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06603285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06603285, "A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06603285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*